Policy & Regulation: Page 26

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive Appointments and Promotions Pharma POOL Dr. Corey Goodman Dr. Martin Mackay Dr. Briggs Morrison Pfizer Announces Executive Changes Pfizer has launched an independent, stand-alone biotherapeutics and bioinnovation center under the direction of scientist and entrepreneur Corey Goodman, Ph...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Internationally renowned vaccines, immunology, and virology expert Paul A. Offit, M.D., has dedicated his career to discovering vaccines to prevent infectious diseases, and is the co-inventor of the rotavirus vaccine, RotaTeq, developed by Merck. A pediatrician, author, and scientific researcher,...

    By PharmaVoice Team • Jan. 2, 2008
  • rare disease ribbon Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Rare diseases

    As drug developers find promise in the rare diseases, deals and treatments are on the rise

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Thomson Scientific Offers Data Platform for Researchers Thomson Scientific has released BONDplus, an integrated, Web-based data platform designed to deliver real-time, comprehensive public and proprietary biological sequence, inte...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies inVentiv Health Creates Patient Outcomes Segment New division combines capabilities that help patients achieve optimum health. inVentiv Health has launched inVentiv Patient Outcomes, a business segment focused on helping pharmaceutical comp...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Industry Events January 2008 January 15-16 2nd Annual Medical Science Liaison Skill Set Training Doubletree Hotel Philadelphia, Philadelphia For more information, contact Andrea Chadis, Center for Business Intelligence, at 781-939-2428, e-mail [email protected], or visit cbinet.com. January 15-...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Pharmacists Could Impact $145 Billion in Drug Sales in Five Years One state, Florida, already allows pharmacists to independently prescribe prescription drugs, and new research suggests six other states may soon give pharmacists this pow...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    When the Stars Align

    By Robin Robinson The practice of using celebrities in marketing campaigns has not lost its luster, but the pharma industry is more selective in choosing icons who match brand images. As the industry approaches the 10th anniversary of the FDA’s ruling to allow DTC and subsequently the industry’s ...

    By Robin Robinson • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Human Resource Related Issues

    Otuska America Pharmaceutical’s Lorraine Daly, Leslie Eggleston, and Richard Obring discuss how HR issues, including compliance, compensation, and staffing can impact a pharmaceutical company’s culture. Otsuka’s Human Resources Department is responsible for more than 600 Otsuka employees in the U...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    Contributed by Craig A. DeLarge Craig A. DeLarge discusses Web 2.0’s drawbacks and opportunities. January 2008 Web 2.0 — Opportunities and Drawbacks n the last month, I have been intensely researching the Web 2.0 phenomenon with respect to its healthcare manifestations. This research has involved...

    By Craig A. DeLarge • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Finding the Right Path -- Jane Hollingsworth

    NuPathe cofounder and CEO Jane Hollingsworth has a fearless attitude about the risks involved in starting and running a business — and defines what it means to be an entrepreneur. Competitive by nature and with a fearless attitude when it comes to the risks involved in starting and running a busi...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    By Taren Grom, Editor I’m getting ready for Web. 2.0. Is your avatar up to date and ready to navigate the “new” World Wide Web? Web 2.0, social networking, or as the contributing author of this month’s Outlet refers to the recent phenomenon “the collective Web,” is seemingly on the tip of everyon...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Milestones In More than 1 Million Served InfoMedics Inc. recently reached a set of significant milestones, including the enrollment of the 1 millionth patient and 500,000th physician in the course of implementing more than 150 patient-physician communications programs for 14 of the top 15 pharmac...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Delivering New Hope

    In a bid to tackle patient compliance, improve treatments, and maximize drug sales, companies are increasingly looking to emerging drug delivery technologies. By Kim Ribbink Necessity is the mother of invention. In the pharmaceutical industry “necessity” might be characterized as patent expiratio...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Doctors' Choice Awards

    The doctors’ choice awards, an annual study conducted by the Association of Medical Media (formerly the Association of Medical Publications), is the only program that is voted on by the industry’s customers — the physicians. Winners are selected according to their scores in an independent Interne...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    What’s New New Healthcare-related Products, Services, and Companies CommonHealth Seeks to Enhance Healthcare with Launch of EvoLogue The agency is focusing on evolving the healthcare dialogue. CommonHealth Consumer Group (CCG) has launched EvoLogue, a full-service consumer agency providing insigh...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The FDA

    A new law is expected to have an immediate and significant impact on the Food and Drug Administration. By Denise Myshko Tightening the Regulatory Reins The new law passed in September 2007 is expected to have an immediate and significant impact on the Food and Drug Administration’s authority over...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    November 15 The Pharmaceutical Business From Drug Discovery Through Product Launch Workshop The Learning Key, Washington Crossing, Pa. For more information, contact Marianne Speiser, The Learning Key, at 215-493-9641, e-mail [email protected], or visit thelearningkey.com. November 15-16...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Scientific Splashdown Pharma Provides Robust Level of Information According to its most recent quarterly review of scientific literature on drugs and therapies, Thomson Scientific reported that Novartis gained pole position knocking GlaxoSmithKline out of the top spot for the first time since Jun...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Table of Contents November/December 2007 An Industry Overview To make the most of future growth opportunities, the industry must fundamentally change the way it operates. Then & Now Thought leaders review their 2006 predictions in 2007. Crystal Ball Industry experts identify the top trends th...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Corner Office

    A review of commentary from more than two dozen of the CEOs and Presidents of leading life-sciences companies reveals some top trends. A review of the annual reports, public statements, and exclusive commentary from almost two dozen of the industry’s pharmaceutical/biotechnology companies reveals...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    By Taren Grom, Editor Contemplating the year ahead As we move into 2008, it appears that there are many more questions than answers for the industry. Certainly, the upcoming presidential election is on everyone’s minds. The healthcare platforms presented by the front runners are being dissected a...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Salesforces

    By Taren Grom, Editor A new sales model will emerge that uses sophisticated selling techniques, technologies, and education. The Salesforce of the Future In the future, the salesforce army of today will be but a distant memory as a new sales model emerges that uses sophisticated selling technique...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Biogenerics at a Crossroads

    By Cynthia Borda Over the past few years, several forces have begun to converge that will likely shift the entire biomarket’s dynamics. Patents of top-selling biotechnology products have lost or will lose patent protection in the next half dozen years (see chart on page 46 for more information). ...

    By Cynthia Borda • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    Contributed by Natalie Douglas Named Patient Programs Yield Significant Results Access to information about drug development and clinical pipelines has become readily available on a worldwide basis. Physicians and patients are now more informed than ever before about innovative drugs in late-stag...

    By Natalie Douglas • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Adaption Adoption

    By Denise Myshko The double-blind, randomized, parallel group design of clinical trials is so entrenched with well-established processes and systems in the industry that to even consider a change in structure may seem like an uphill battle. But many in the pharmaceutical industry — from pharmaceu...

    By Denise Myshko • Jan. 2, 2008